About Indivior PLC - INDV.L
Indivior PLC is a pharmaceutical company that specializes in developing and marketing treatments for addiction and related disorders, notably focusing on opioid dependence. Its most well-known product is Suboxone, a medication designed to treat opioid addiction by reducing withdrawal symptoms and discouraging misuse.
What are Indivior PLC's core values and mission statement?
Indivior PLC's mission is to pioneer life-transforming treatments for patients struggling with addiction and serious mental illness. Their core values include a commitment to patient-centricity, integrity, innovation, and collaboration in pursuit of developing therapies that can positively alter the course of these challenging conditions.
Who founded Indivior PLC and when?
Indivior PLC was founded in December 2014 when it was demerged from Reckitt Benckiser's pharmaceuticals division.
Who leads Indivior PLC?
As of the last update, Mark Crossley is the CEO of Indivior PLC. Please note that executive leadership can change and you may want to check the latest information from the company for the current CEO.
Where is Indivior PLC located, and what is its base country?
Indivior PLC is headquartered in Slough, England, and its base country is the United Kingdom.
On which exchanges is Indivior PLC traded?
Indivior PLC is listed on the London Stock Exchange (LSE) under the ticker symbol INDV.
Indivior PLC (INDV) Price Live Data
The live price of Indivior PLC (INDV) is $16.01, with a trading volume of 93,103 in the last 24 hours. Wrapstocks updates the INDV price in real-time. Indivior PLC is down -0.46% in the last 24 hours. The company has a live market cap of $22,598,400.69 and a supply of 1,411,520 INDV stocks.
Indivior PLC (INDV) is traded on London Stock Exchange, and currently, the market is open; trading will be paused in 3 hours and 21 minutes.